1.72
price down icon5.49%   -0.10
after-market Dopo l'orario di chiusura: 1.71 -0.01 -0.58%
loading

Nkarta Inc Borsa (NKTX) Ultime notizie

pulisher
Mar 13, 2025

Nkarta (NKTX) Projected to Post Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 01, 2025

Comparing Tempest Therapeutics (NASDAQ:TPST) & Nkarta (NASDAQ:NKTX) - Defense World

Mar 01, 2025
pulisher
Feb 25, 2025

Nkarta to Participate in March Investor Conferences - The Manila Times

Feb 25, 2025
pulisher
Feb 18, 2025

Leerink Partnrs Forecasts Nkarta FY2029 Earnings - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

Leerink Partnrs Comments on Nkarta FY2024 Earnings - Defense World

Feb 17, 2025
pulisher
Feb 16, 2025

Leerink Partnrs Comments on Nkarta FY2029 Earnings - Defense World

Feb 16, 2025
pulisher
Feb 15, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Feb 15, 2025
pulisher
Feb 11, 2025

Stock Performance Spotlight: Nkarta Inc (NKTX) Ends the Day at 2.09, Down by -3.69 - The Dwinnex

Feb 11, 2025
pulisher
Feb 11, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Rating of “Buy” by Brokerages - Defense World

Feb 11, 2025
pulisher
Feb 06, 2025

A new trading data show Nkarta Inc (NKTX) is showing positive returns. - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Vasculitis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | R-Pharm Overseas, Abbvie, Toleranzia, Ambulero, Visterra, CytoDyn - The Globe and Mail

Feb 06, 2025
pulisher
Feb 05, 2025

Monitoring Nkarta Inc (NKTX) after recent insider movements - Knox Daily

Feb 05, 2025
pulisher
Feb 04, 2025

The Potential Rise in the Price of Trane Technologies plc (TT) following insiders activity - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Closing Figures: Nkarta Inc (NKTX)’s Negative Finish at 2.17, Down -7.26 - The Dwinnex

Feb 04, 2025
pulisher
Jan 28, 2025

TANG CAPITAL MANAGEMENT LLC Increases Stake in Nkarta Inc - GuruFocus.com

Jan 28, 2025
pulisher
Jan 27, 2025

What Does Nkarta Inc’s (NASDAQ: NKTX) Future Hold? - Stocks Register

Jan 27, 2025
pulisher
Jan 21, 2025

Nkarta's chief medical officer sells $19,003 in stock - MSN

Jan 21, 2025
pulisher
Jan 21, 2025

Nkarta CEO Paul Hastings sells $38,231 in stock - MSN

Jan 21, 2025
pulisher
Jan 19, 2025

Nkarta executive sells shares worth $12,843 - MSN

Jan 19, 2025
pulisher
Jan 18, 2025

Nkarta's chief technical officer sells $16,383 in stock By Investing.com - Investing.com Australia

Jan 18, 2025
pulisher
Jan 18, 2025

Nkarta chief legal officer Alicia Hager sells $21,084 in stock - Investing.com India

Jan 18, 2025
pulisher
Jan 18, 2025

Nkarta chief legal officer Alicia Hager sells $21,084 in stock By Investing.com - Investing.com Australia

Jan 18, 2025
pulisher
Jan 18, 2025

Nkarta, Inc. (NASDAQ:NKTX) Insider Sells $19,003.60 in Stock - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Nkarta, Inc. (NASDAQ:NKTX) CEO Sells $38,231.60 in Stock - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

JPMorgan Chase & Co. Purchases 761,349 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Jan 18, 2025
pulisher
Jan 18, 2025

Nkarta executive sells shares worth $12,843 By Investing.com - Investing.com South Africa

Jan 18, 2025
pulisher
Jan 17, 2025

Nkarta's chief medical officer sells $19,003 in stock By Investing.com - Investing.com South Africa

Jan 17, 2025
pulisher
Jan 17, 2025

Nkarta's chief technical officer sells $16,383 in stock - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Nkarta, Inc. (NASDAQ:NKTX) Receives $15.00 Consensus Target Price from Analysts - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Average Rating of “Buy” by Brokerages - Defense World

Jan 17, 2025
pulisher
Jan 15, 2025

Nkarta, Inc. (NASDAQ:NKTX) Shares Acquired by Barclays PLC - Defense World

Jan 15, 2025
pulisher
Jan 12, 2025

Jane Street Group LLC Lowers Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Jan 12, 2025
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Capitalizzazione:     |  Volume (24 ore):